Has Ezequiel Munoz Gonzalez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $55,126 in general payments to Ezequiel Munoz Gonzalez, MD across 201 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ezequiel Munoz Gonzalez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ezequiel Munoz Gonzalez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ezequiel Munoz Gonzalez, MD

Interventional Cardiology · Carmel, INNPI 1598118408

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (55.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Abbott at 39.4% of the total. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,126in general payments, 2019–2025

Across 201 payments — averaging $274.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$22K
Medtronic$22K
Edwards Lifesciences$6K
W. L. Gore & Associates, Inc.$2K
Abiomed$527
Johnson & Johnson$459
plus $3K from 18 others

What the payments were for

Consulting fees$2,6505%
Grants$30,35855%
Travel & lodging$10,94320%
Food & beverage$10,98720%
Education$1880%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	63	$21,713
Medtronic(2 entities)	39	$21,674
Edwards Lifesciences	37	$6,149
W. L. Gore & Associates, Inc.	14	$1,899
Abiomed	6	$527
Johnson & Johnson	5	$459
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$387
Shockwave Medical, Inc	4	$275
Boston Scientific	2	$273
Cardiovascular Systems Inc.	2	$272
Heartflow, Inc.	5	$256
Biotronik Inc.	2	$241
Chiesi USA, Inc.	2	$163
AstraZeneca	1	$132
Angiodynamics, Inc.	2	$123
GE HealthCare	1	$100
Bayer	1	$100
Teleflex LLC	1	$96
E.r. Squibb & Sons, L.L.C.	1	$76
Inari Medical, Inc.	1	$71
Baxter Healthcare	1	$58
Getinge USA Sales, LLC	3	$52
Gilead	1	$17
Cordis US CORP.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$16,057
RESOLUTE ONYX$4,000
TRICLIP$2,887
SAPIEN 3 Ultra RESILIA$2,583
Edwards SAPIEN 3 Transcatheter Heart Valve$1,822
MitraClip$1,764
NAVITOR$922
GORE CARDIOFORM Septal Occluder$867
GORE CARDIOFORM ASD Occluder$669
XARELTO$358
DRAGONFLY OPSTAR$332
WATCHMAN Access System$273
Diamondback Coronary$272
Impella$242
Orsiro Mission$241
PK Papyrus$241
PASCAL$215
ONYX FRONTIER$203
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$156
FFRct$147

How this compares

$55,126 in reported general payments places this provider in the 90th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana →

Medicare billing

Part B allowed, 2024

$53,492

Medicare patients

307

Services billed

494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	11	$127
ClopidogrelClopidogrel Bisulfate	20	$98

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Carmel

Samer AbbasEast Chicago$395K
James HermillerIndianapolis$307K
Woodrow CoreyIndianapolis$262K
Muzammil MusaniFort Wayne$184K
Dean FerreraEast Chicago$180K
Shashidhar DivakaruniMunster$97K
Jarrod FrizzellEvansville$86K
Navneet LatherNoblesville$83K
Michael BallIndianapolis$76K
Anjan SinhaIndianapolis$54K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →